ArticleCureus2025
Effect of Non-surgical Periodontal Therapy on Levels of Ghrelin and Tumor Necrosis Factor-Alpha (TNF-α) in the Gingival Crevicular Fluid of Healthy and Periodontitis Patients With and Without Type 2 Diabetes Mellitus: A Clinico-Biochemical Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePeriodontitis, a chronic inflammatory disease, is closely associated with type 2 diabetes mellitus (T2DM). Ghrelin, a stomach-derived peptide hormone, may influence periodontal health by modulating inflammation through its receptor growth hormone secretagogue receptor (GHS-R1a), notably by inhibiting lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-α) production in oral epithelial cells.
aimTo compare and correlate the gingival crevicular fluid (GCF) ghrelin and TNF-α levels in healthy individuals and stage III grade B periodontitis patients with and without T2DM before and three months after non-surgical periodontal therapy (NSPT). MATERIALS AND
methodsNinety subjects were segregated into three groups: Group I (healthy), Group II (Stage III Grade B periodontitis), and Group III (periodontitis with controlled T2DM). Clinical parameters such as plaque index (PI), gingival index (GI), bleeding on probing (BoP), probing pocket depth (PPD), and interdental clinical attachment loss (ICAL) were recorded along with GCF samples which were collected and analysed at baseline and at the end of three months post NSPT.
resultsBaseline GCF levels of ghrelin and TNF-α differed significantly among the three groups. Three months after NSPT, all the groups exhibited a significant reduction in ghrelin and TNF-α levels in GCF, with the greatest reduction observed in Group III.
conclusionOur findings suggest that ghrelin and TNF-α levels may serve as useful biomarkers for evaluating periodontal disease severity and treatment response, especially in patients with T2DM. The study also confirms the effectiveness of NSPT in reducing inflammation, highlighting its critical role in managing periodontitis among individuals with systemic conditions like T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.